Patent application number | Description | Published |
20100286237 | PRO-ANGIOGENIC GENES IN OVARIAN TUMOR ENDOTHELIAL CELL ISOLATES - A gene profiling signature for ovarian tumor endothelial cells is disclosed herein. The gene signature can be used to diagnosis or prognosis an ovarian tumor, identify agents to treat an ovarian tumor, to predict the metastatic potential of an ovarian tumor and to determine the effectiveness of ovarian tumor treatments. Thus, methods are provided for identifying agents that can be used to treat ovarian cancer, for determining the effectiveness of an ovarian tumor treatment, or to diagnose or prognose an ovarian tumor. Methods of treatment are also disclosed which include administering a composition that includes a specific binding agent that specifically binds to one of the disclosed ovarian endothelial cell tumor-associated molecules and inhibits ovarian tumor in the subject. | 11-11-2010 |
20100292303 | GENE EXPRESSION PROFILE FOR PREDICTING OVARIAN CANCER PATIENT SURVIVAL - A gene profiling signature for predicting ovarian cancer patient survival is disclosed herein. The gene signature can be used to diagnosis or prognosis ovarian cancer, identify agents to treat an ovarian tumor, to predict the metastatic potential of an ovarian tumor and to determine the effectiveness of ovarian tumor treatments. Thus, methods are provided for diagnosing and prognosing an ovarian tumor, such as ovarian cancer, in a subject. Methods are also provided for identifying agents that can be used to treat an ovarian tumor, for determining the effectiveness of an ovarian tumor treatment, or to predict the metastatic potential of an ovarian tumor. Methods of treatment are also disclosed which include administering a composition that includes a specific binding agent that specifically binds to one of the disclosed ovarian survival factor-associated molecules and ovarian tumor in the subject. | 11-18-2010 |
20110178154 | GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY - A gene profiling signature is disclosed herein. The gene signature can predict whether a subject with ovarian cancer will be chemorefractory, chemoresistant or chemosensitive. Thus, methods are disclosed for determining whether a subject with ovarian cancer is sensitive to treatment with a chemotherapeutic agent. Methods are also provided for increasing sensitivity to the chemotherapeutic agent if the presence of differential expression indicates that the ovarian cancer has a decreased sensitivity to chemotherapeutic agent. | 07-21-2011 |
20130274315 | PRO-ANGIOGENIC GENES IN OVARIAN TUMOR ENDOTHELIAL CELL ISOLATES - A gene profiling signature for ovarian tumor endothelial cells is disclosed herein. The gene signature can be used to diagnosis or prognosis an ovarian tumor, identify agents to treat an ovarian tumor, to predict the metastatic potential of an ovarian tumor and to determine the effectiveness of ovarian tumor treatments. Thus, methods are provided for identifying agents that can be used to treat ovarian cancer, for determining the effectiveness of an ovarian tumor treatment, or to diagnose or prognose an ovarian tumor. Methods of treatment are also disclosed which include administering a composition that includes a specific binding agent that specifically binds to one of the disclosed ovarian endothelial cell tumor-associated molecules and inhibits ovarian tumor in the subject. | 10-17-2013 |
Patent application number | Description | Published |
20090268732 | Channel change tracking metric in multicast groups - A method, device and computer readable medium that measures the error rate in a network data stream to a device, for example a Set Top Box. The method including joining one or more multicast groups representing audio and or video data for a requested channel; discarding a predetermined number of received packets for each of the joined multicast groups; and comparing a sequence number of a first packet received subsequent to the predetermined number of discarded packets to a sequence number of a next subsequent received packet in order to determine a sequence error. The method may further include tracking sequence numbers of received packets for one or more of the joined multicast groups; incrementing a packets received counter for each received packet for one or more of the joined multicast groups; and comparing each received sequence number with the next received sequence number in order to determine sequence errors. | 10-29-2009 |
20090271835 | Set top box system parameter retrieval - A method, system and computer readable medium box is disclosed for determining a networked device connection status of an IP set top. A signal strength parameter request is generated associated with the networked device's operation. This request is transmitted to a specific point in a network system where it is received at specific hardware and/or software point. Then a reply or signal strength parameter is generated in response to the signal strength parameter request. This reply or signal strength parameter is transmitted across the network system from the specific hardware and/or software point back to the networked device. There it is loaded into a signal strength parameter variable and displayed to the user. | 10-29-2009 |
20090296735 | Software assisted multicast filtering - A method is described including determining if a packet length parameter included in received data matches a first pre-determined value, determining if an address parameter included in received data matches an address of a receiving device, determining if a length parameter included in received data matches a second pre-determined value, determining if a packet destination port number parameter included in received data matches a third pre-determined value, determining if a packet payload type parameter included in received data matches a fourth pre-determined value and dropping the packet responsive to the matches. | 12-03-2009 |